Bayer CropScience Q4 FY19 earnings call: Revenue & Margins
Q4 FY19 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #15 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
Bayer CropScience Ltd Q4 FY19 key numbers
- Revenue
- Q1 2019 Crop Science segment sales: €6,444 million, +5.5% year-on-year (YoY) currency- and portfolio-adjusted.
As stated in Bayer CropScience Ltd's Q4 FY19 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Bayer CropScience Ltd's Q4 FY19 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1 2019 Crop Science segment sales: €6,444 million, +5.5% year-on-year (YoY) currency- and portfolio-adjusted - Pharmaceuticals sales: €4,354 million, +5.3% YoY
From Bayer CropScience Ltd's Q4 FY19 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 2019 Crop Science segment sales: €6,444 million, +5.5% year-on-year (YoY) currency- and portfolio-adjusted
- Pharmaceuticals sales: €4,354 million, +5.3% YoY
- Consumer Health sales: €1,395 million, –1.4% YoY
- Animal Health sales: €421 million, –0.9% YoY
- Crop Science EBITDA before special items grew +122.8% YoY
2 more points from Bayer CropScience Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Bayer CropScience Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Bayer CropScience Ltd said on order book & pipeline — free account, 30 seconds.
Bayer CropScience Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bayer CropScience's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bayer CropScience Ltd Q4 FY19 results?
Q1 2019 Crop Science segment sales: €6,444 million, +5.5% year-on-year (YoY) currency- and portfolio-adjusted - Pharmaceuticals sales: €4,354 million, +5.3% YoY
What is Bayer CropScience Ltd share price analysis?
Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
